{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:31:31Z","timestamp":1792359091808,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.msard.2020.102021","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T17:58:26Z","timestamp":1582394306000},"page":"102021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod"],"prefix":"10.1016","volume":"41","author":[{"given":"Mohammad Hossein","family":"Harirchian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Poursadeghfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Sadeghipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.msard.2020.102021_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.05.010","article-title":"Pathology and disease mechanisms in different stages of multiple sclerosis","volume":"333","author":"Lassmann","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2020.102021_bib0002","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0317167100014244","article-title":"Treatment optimization in MS: Canadian MS working group updated recommendations","volume":"40","author":"Freedman","year":"2013","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.msard.2020.102021_bib0003","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrneurol.2010.76","article-title":"Fingolimod is a potential novel therapy for multiple sclerosis","volume":"6","author":"Aktas","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"Suppl 2","key":"10.1016\/j.msard.2020.102021_bib0004","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.cmi.2018.01.030","volume":"2","author":"Redelman-Sidi","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"issue":"6","key":"10.1016\/j.msard.2020.102021_bib0005","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s10067-005-0095-z","article-title":"Sporothrix schenckii infection presented as monoarthritis: report of two cases and review of the literature","volume":"25","author":"Appenzeller S","year":"2006","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.msard.2020.102021_bib0006","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/01676830500187696","article-title":"Voriconazole in the treatment of fungal osteomyelitis of the orbit in the immunocompromised host","volume":"24","author":"O'Doherty M","year":"2005","journal-title":"Orbit"},{"issue":"3","key":"10.1016\/j.msard.2020.102021_bib0007","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5114\/ceji.2015.54599","article-title":"Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study","volume":"40","author":"Rudnicka","year":"2015","journal-title":"Cent.-Eur. j. immunol."},{"key":"10.1016\/j.msard.2020.102021_bib0008","article-title":"Warts and all: Fingolimod and unusual HPV-associated lesions","author":"Triplett","year":"2018","journal-title":"Mult. Scler."},{"issue":"22","key":"10.1016\/j.msard.2020.102021_bib0009","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.2169\/internalmedicine.55.7255","article-title":"Disseminated cryptococcosis in a 63-year-old patient with multiple sclerosis treated with fingolimod","volume":"55","author":"Seto","year":"2016","journal-title":"Intern. Med."},{"issue":"10","key":"10.1016\/j.msard.2020.102021_bib0010","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaneurol.2015.1746","article-title":"Cryptococcal meningoencephalitis in a patient with multiple sclerosis treated with fingolimodcryptococcal meningoencephalitis in multiple sclerosisletters","volume":"72","author":"Achtnichts","year":"2015","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.msard.2020.102021_bib0011","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1352458516670732","article-title":"Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: here come the opportunistic infections?","volume":"23","author":"Carpenter","year":"2017","journal-title":"Mult. Scler. J."},{"issue":"6","key":"10.1016\/j.msard.2020.102021_bib0012","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/1203475417719043","article-title":"Primary cutaneous histoplasma capsulatum infection in a patient treated with fingolimod: a case report","volume":"21","author":"Veillet-Lemay","year":"2017","journal-title":"J. Cutan. Med. Surg."},{"issue":"2669","key":"10.1016\/j.msard.2020.102021_bib0013","article-title":"Real world lab data: patterns of lymphocyte counts in fingolimod treated patients","volume":"9","author":"Kaufmann","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2020.102021_bib0014","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12281-014-0200-3","article-title":"Epidemiology of fungal osteomyelitis","volume":"8","author":"Gamaletsou","year":"2014","journal-title":"Curr. Fungal Infect. Rep."},{"key":"10.1016\/j.msard.2020.102021_bib0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2334-14-166","article-title":"Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series","volume":"14","author":"Delsing","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.msard.2020.102021_bib0016","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40120-019-00162-7","article-title":"Fingolimod immune effects beyond its sequestration ability","volume":"8","author":"Sica","year":"2019","journal-title":"Neurol. Ther."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820300973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820300973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:47:29Z","timestamp":1761900449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820300973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":16,"alternative-id":["S2211034820300973"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102021","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102021"}}